Top Stock Gainers

Materion reported record sales, EPS and EBITDA, raised full-year adjusted EPS guidance to $6.80–$7.20 and expects mid‑teens revenue growth. Backlog and orders strengthened across semiconductors, defense/space and data centers, though management flagged margin, R&D and backlog risks.

Materion  ·  Updated Aug 6

Select Water Solutions is trading significantly higher today after reporting second-quarter 2026 financial results that exceeded analyst expectations for both earnings and revenue. The company achieved record performance in its Water Infrastructure and Chemical Technologies segments, while also raising its capital spending outlook following a new long-term pipeline agreement in the Northern Delaware Basin. This company-specific surge is driven by a sequential doubling of net income and Adjusted EBITDA that substantially outperformed previous management guidance.

Select Energy Services  ·  Updated Aug 5

Bending Spoons opened a Madrid office, its third European base after Milan and London, and agreed to acquire Airtable in an all-cash transaction valuing Airtable at $1.29B EV (about $2.25B equity). The boards approved the deal; closing awaits regulatory approvals later this year.

Bending Spoons  ·  Updated Aug 5

Twist completed a fully subscribed equity offering raising about $327.1M to fund R&D, expand manufacturing and product offerings, and support working capital. Analysts lifted targets, citing durable AI‑driven demand and progress toward a cash‑generating operating model. The firm granted inducement RSUs.

Twist Bioscience  ·  Updated Aug 5

Hagerty raised its full-year adjusted EBITDA outlook after strong first-half performance, citing growth across insurance, auctions and its Hagerty Marketplace, surpassing three million insured vehicles, and expanding U.K. motorcycle insurance by acquiring Bennetts to boost scale.

Hagerty Inc Class A  ·  Updated Aug 5

Freshpet reported Q2 revenue of $305.6M, stronger margins and adjusted EBITDA of $52.2M. Management raised its FY26 sales outlook and adjusted EBITDA guidance to $210–220M, lifted long‑term margin targets, cited manufacturing scale and omnichannel growth, and drew supportive analyst revisions. Oppenheimer meeting Aug 11–12.

Freshpet  ·  Updated Aug 5

Aura Minerals reported record H1 2026 output and higher adjusted EBITDA, declared a US$0.72 per-share dividend (~US$60M) and a up-to-US$200M buyback, and is advancing growth projects: Era Dorada construction, MSG turnaround, Almas and Borborema expansions and Matupá studies.

Aura Minerals  ·  Updated Aug 5

Several analysts raised Qualys price targets, citing stronger business trends: improving competitive position, ETM adoption, channel and international strength, remediation growth, and higher FY26 revenue and guidance expectations.

Qualys  ·  Updated Aug 5

Analysts raised price targets after Intapp’s recent update, citing accelerating subscription growth, improved profitability and cash flow, rising ARR, growing AI bookings and Celeste adoption. Management highlighted progress on its Firm AI strategy and agentic Celeste platform.

Intapp  ·  Updated Aug 5

Shake Shack reported Q2 revenue of $417.6M, saw same-Shack sales growth, and opened 16 company-operated Shacks (33 YTD), on track for 60–65 openings. Starboard Value disclosed a several-hundred-million-dollar stake and urged U.S. franchising; analysts are largely neutral, noting potential catalysts and modest price-target tweaks.

Shake Shack  ·  Updated Aug 5

Multiple analysts raised Travere’s price targets and kept positive ratings, citing strong FILSPARI momentum, IgAN growth and early FSGS demand. The company also disclosed a new regulatory risk: evolving cross-border investment and tech-transfer rules could complicate partnerships and timelines.

Travere Therapeutics  ·  Updated Aug 6

Multiple analysts raised price targets and kept buy/outperform calls, citing momentum as Zeta’s Athena AI and Data Cloud boost customer spend and retention. The company highlighted collaborations with OpenAI, Snowflake and Palantir and raised its FY26 revenue view.

Zeta Global Holdings Corp  ·  Updated Aug 5

Analysts raised targets and turned more positive after strong Q2 and robust bookings, citing a broad recovery in discovery and safety testing. Charles River said it is advancing its Pathway to Purpose plan and evaluating modernization to boost efficiency and growth.

Charles River Labs  ·  Updated Aug 6

Dynatrace reported strong demand, accelerating ARR and AI/log consumption, raised revenue and margin outlook, increased buybacks, and said CFO Jim Benson will retire by March 31, 2027 with a successor search underway; analysts generally raised price targets.

Dynatrace  ·  Updated Aug 6

Perpetua Resources Corp. is surging today following the U.S. Forest Service's issuance of a conditional Notice to Proceed for the Stibnite Gold Project, which officially transitions the site into the development phase. The stock is also being driven by a significant rally in gold and antimony prices and its strategic role in securing domestic supply chains for the U.S. military. This movement is further bolstered by improved market risk appetite as geopolitical tensions ease, lifting the broader materials and mining sector.

Perpetua Resources  ·  Updated Aug 5

Champion Homes closed the Homes Direct deal on Aug 1, adding 11 stores and about $70M in annual sales, expanded backlog to $421.8M, improved plant utilization, boosted cash and repurchased $50M of stock, while warning of near-term margin pressure and higher tax expenses.

Champion Homes  ·  Updated Aug 6

Sunshine Silver Mining and Refining SSMR is trading significantly higher today, likely fueled by positive momentum from its recent high-grade drill results and a favorable mention in a Motley Fool investment commentary published this morning. The stock is also experiencing a technical rebound as it recovers from post-IPO lows, attracting investors looking for growth in the precious metals sector following recent earnings disappointments from industry peers.

Sunshine Silver Mining & Refining Co.  ·  Updated Aug 5

Griffon closed the sale of AMES Australasia into a joint venture, retaining 49% and receiving AUD 258M cash plus an AUD 69.3M PIK note. It used proceeds to repay a $285M term loan, reshaping its capital structure, and set fiscal 2026 guidance of $1.8B revenue and $458M adjusted EBITDA.

Griffon  ·  Updated Aug 5

Gold Fields (GFI) is trading significantly higher today as spot gold prices surged above $4,130 per ounce, driven by intensified safe-haven demand following escalating geopolitical tensions in the Middle East. This sector-wide upward momentum is further supported by strong investor conviction in major gold producers as macroeconomic uncertainty continues to bolster the metal's appeal. The move appears to be primarily driven by these broader commodity and geopolitical trends rather than company-specific news.

Gold Fields  ·  Updated Aug 5

SSR Mining shares are surging today following the company's second-quarter 2026 earnings report, which featured the reinstatement of a quarterly cash dividend and the approval of an additional 500 million dollar share buyback program. Despite missing analyst estimates on revenue and earnings, investor sentiment is buoyed by a transformational strategic shift to an Americas-focused portfolio and a debt-free balance sheet with nearly 1.8 billion dollars in cash following the sale of its Copler mine. The stock is also benefiting from broader sector strength as gold prices remain elevated, providing a tailwind for precious metals producers.

SSR Mining  ·  Updated Aug 5

International Flavors & Fragrances (IFF) shares are surging today following the company's second-quarter 2026 earnings report, which featured a new 2.5 billion dollar share buyback authorization and strong organic revenue growth of 6 percent. Although the company missed headline earnings and revenue estimates and lowered its full-year guidance, investors are reacting positively to significant gross margin expansion and a strategic plan to use divestiture proceeds for substantial debt reduction. The stock's upward momentum is further supported by several analyst price target increases and a market focus on the company's successful transition toward higher-margin core business segments.

International Flavors & Fragrances  ·  Updated Aug 5

Primo Brands reported Q2 revenue of $1.8B and raised 2026 comparable net sales guidance to 2–4%. Management reaffirmed FY26 adjusted EBITDA and free cash flow targets, pointed to retail and premium brand strength and an earlier direct delivery recovery while managing integration and freight headwinds.

Primo Brands  ·  Updated Aug 6

AngloGold Ashanti AU shares are rising significantly today, August 5, 2026, as gold prices surged above $4,130 per ounce following reports of a potential diplomatic resolution to reopen the Strait of Hormuz. This commodity-driven rally is bolstered by a positive market reassessment of the company's Q2 2026 results, which featured record free cash flow and a swing to a $991 million net cash position. Investor sentiment is also being lifted by the recent approval of a $2 billion share buyback program and a substantial increase in interim dividend payouts.

Anglogold Ashanti PLC  ·  Updated Aug 5

Supernus Pharmaceuticals is moving significantly higher following the announcement of a definitive all-stock merger of equals with Indivior Pharmaceuticals to create a leading CNS-focused biopharmaceutical company. The stock's momentum is further bolstered by second-quarter 2026 revenue that exceeded analyst estimates and a raised full-year revenue outlook, which offset a GAAP net loss driven by a non-cash impairment charge. This company-specific rally reflects investor optimism regarding the projected 125 million dollars in annual cost synergies and the combined entity's expanded commercial portfolio.

Supernus Pharmaceuticals  ·  Updated Aug 5

SharkNinja reported $1.77B revenue and 22.2% sales growth; it raised FY2026 outlook for sales, adjusted EPS ($6.45–$6.55) and EBITDA, and expects a ~$247.1M tariff refund accepted by CBP to be recognized in Q3 and partly reinvested. Analysts broadly lifted targets.

SharkNinja, Inc.  ·  Updated Aug 5

Hemab Therapeutics (COAG) is trading significantly higher today following a positive sector-wide catalyst from Charles River Laboratories, which raised its 2026 profit forecast due to strengthening demand for drug discovery services from biotechnology clients. The stock is also gaining momentum from renewed acquisition speculation after being highlighted in industry reports as a prime M&A target following successful clinical data presentations for its lead candidate, sutacimig. This upward move is further supported by a broader rally in the biotech IPO market, reinforced by the successful market debut of Attovia Therapeutics on the same day.

Hemab Therapeutics Holdings, Inc.  ·  Updated Aug 5

Coeur said Q2 momentum came from first full-quarter contributions of New Afton and Rainy River. Rochester set a quarterly tonnes record and Wharf nearly doubled output. The company launched enhanced capital returns with $121M buybacks, an inaugural dividend and over $1B cash. Analysts were mixed.

Coeur Mining  ·  Updated Aug 5

Hecla Mining (HL) is trading significantly higher today following its second-quarter 2026 earnings report, which highlighted record free cash flow of $136 million and a new quarterly production record at the Lucky Friday mine. Although the company missed consensus estimates for revenue and earnings per share, investors are focusing on the Keno Hill mine reaching positive free cash flow and a broader rally in silver prices to over $62 per ounce. The stock's gains are further supported by a strengthened balance sheet and a transition to a net cash position, reflecting strong operational momentum across its North American assets.

Hecla Mining Company  ·  Updated Aug 5

NGL Energy Partners is trading significantly higher today after reporting a substantial fiscal first quarter 2027 earnings beat of $0.48 per unit and raising its full-year adjusted EBITDA guidance due to record volumes in its Water Solutions segment. The partnership's stock is also benefiting from management's announcement of plans to redeem 50% of its Class D preferred stock and the potential reinstatement of common unit distributions later in 2027. This company-specific momentum reflects a strengthened balance sheet and a successful strategic pivot toward fee-based water handling contracts in the Permian Basin.

NGL Energy Partners  ·  Updated Aug 5

On its Q2 call Assurant reported record results and broad-based growth led by Connected Living, Housing and Automotive. Management raised its full-year outlook, highlighted tech and partnership wins (Freedom Mortgage, T‑Mobile, Best Buy), boosted buybacks and noted reserve and ramp timing headwinds.

Assurant  ·  Updated Aug 6

Harmony Gold Mining shares are surging today following reports of strong operational performance in its copper segment, which achieved a 42 million dollar profit in the third quarter of fiscal 2026. The stock is also benefiting from management's target to double copper production in the fourth quarter and a broader sector-wide rally driven by record-high gold prices. This upward momentum reflects positive market sentiment regarding the company's strategic diversification into a dual-basket gold and copper producer following the successful integration of the CSA mine.

Harmony Gold Mining  ·  Updated Aug 5

Multiple analysts raised Compass price targets and maintained positive ratings, citing stronger Anywhere merger synergies, luxury-market resilience and solid management execution. The company’s outlook was updated with higher synergy estimates and a path to positive FY26 free cash flow.

Compass  ·  Updated Aug 5

Heavy bullish options flow in Newmont: about 9,853 calls, a low put/call ratio (0.30) and implied volatility around 42.8%, with Sep‑26 110 and Dec‑28 100 strikes active (~1,500 contracts). Analysts issued mixed price‑target moves and investors flagged Rule 10b5‑1 concerns; earnings Oct 22.

Newmont Mining  ·  Updated Aug 5

Ternium reported a strong operational rebound: rising EBITDA, wider margins and Mexican volume recovery; Pesqueria downstream and a new slab plant are on track for early 2027 and CapEx is set to fall in 2027. A Form 6-K detailed higher H1 sales/profit but noted working-capital, FX and trade risks.

Ternium SA  ·  Updated Aug 6

Kratos reported stronger results, raised revenue and EBITDA guidance, and cited a $2B backlog, $15B bid pipeline and production ramps for MACH‑TB, turbojets and tactical drones. Analysts largely raised targets or upgraded coverage, citing clearer growth visibility and improving margins.

Kratos Defense  ·  Updated Aug 5

Booking reported a strong Q2 with resilient travel demand and increased annual savings from its Transformation Program; management offered cautious near‑term guidance amid Middle East headwinds. Analysts broadly raised targets and the company filed an automatic mixed securities shelf.

Booking Holdings  ·  Updated Aug 5

National HealthCare Corporation (NHC) is likely moving upward in anticipation of its second-quarter 2026 earnings report, which is expected to reflect the first financial results following its $560 million acquisition of 35 facilities in July. Investors are optimistic that this strategic shift from leasing to owning real estate will be immediately accretive to earnings and cash flow, building on the stock's recent momentum and its climb toward all-time highs. This significant price action appears to be company-specific, driven by positive market sentiment surrounding the company's aggressive portfolio expansion and recent dividend growth.

National Healthcare  ·  Updated Aug 5

Equitable reported strong Q2 operating results with record AUM driven by retirement, wealth and asset-management inflows, returned significant capital to shareholders and won stockholder approval for the Corebridge merger; Barclays raised its target and kept Overweight.

Equitable Holdings  ·  Updated Aug 5

Corebridge said shareholders approved its merger with Equitable, refined combined leadership, and is focused on final execution to drive profitable growth and shareholder value. Separately, BofA raised its price target and kept a Buy rating.

Corebridge Financial, Inc.  ·  Updated Aug 5

Indivior agreed to a tax-free merger of equals with Supernus; analysts view the deal positively. Craig-Hallum raised its price target and reiterated a Buy, citing EBITDA upside from the merger; Barclays trimmed its target but kept an Overweight rating and also views the merger positively.

Indivior  ·  Updated Aug 5

Acadia raised FY26 revenue and Daybue guidance after strong Daybue uptake and steady Nuplazid. Multiple analysts raised price targets and affirmed positive views, citing STIX adoption and pointing to the Phase 2 remlifanserin (RADIANT) topline readout in Sept-Oct as the next catalyst.

ACADIA Pharmaceuticals  ·  Updated Aug 5

Innospec Inc. (IOSP) shares are surging today following the release of second-quarter 2026 financial results that significantly exceeded analyst expectations for both earnings and revenue. The specialty chemicals company reported adjusted earnings of $1.27 per share on revenue of $491.4 million, driven by a 16 percent increase in operating income and strong performance across all business segments. This company-specific rally is further supported by the firm's robust debt-free balance sheet and a 12 percent year-over-year increase in total revenue, which propelled the stock to a new 52-week high.

Innospec  ·  Updated Aug 5

BorgWarner won new engine program awards in Europe and China for its center-bolt CTA VCT system, with production starts in Sept 2026 and Jan 2027, and its board boosted share repurchase authorization by $1B to about $1.35B.

BorgWarner  ·  Updated Aug 6

Repligen Corporation RGEN shares are surging following a strong second-quarter 2026 earnings report that featured a significant beat on both revenue and earnings alongside an upward revision to full-year guidance. The stock's upward momentum is further fueled by the announcement of a 1.5 billion dollar strategic acquisition of BioLife Solutions and subsequent analyst upgrades and price target hikes. This significant move is company-specific, reflecting investor confidence in Repligen's accelerating growth in the bioprocessing and cell therapy markets.

Repligen  ·  Updated Aug 5

CorVel Corporation is trading significantly higher today after reporting strong first quarter fiscal year 2027 results, highlighted by an 11 percent revenue increase to 260 million dollars and a 21 percent jump in diluted earnings per share to 0.63 dollars. The company-specific gains are driven by robust growth in its CERIS health division and disciplined capital management, including 21.8 million dollars in share repurchases during the quarter.

CorVel  ·  Updated Aug 5

McKesson reported a strong Q1 with $105.4B revenue, saw solid adjusted EPS growth and raised its full-year adjusted EPS outlook, citing momentum in core distribution, oncology, multispecialty and biopharma services and disciplined capital allocation.

McKesson  ·  Updated Aug 5

H.C. Wainwright raised its price target on Precigen to $18 and kept a Buy after Papzimeos sales nearly doubled expectations in the drug's second full launch quarter. An ESG disclosure flagged perception and governance risk as the CEO repeatedly revised a Rule 10b5-1 trading plan.

Precigen  ·  Updated Aug 6

BillionToOne launched Unity Confirm, said expanded Fetal Risk Screen and Northstar Origin are coming, and reiterated 2026 revenue guidance of $450–465M while aiming to maintain current profitability despite continued investment.

BillionToOne, Inc. Class A  ·  Updated Aug 5

Analysts at Baird and BMO raised Trex price targets and kept Outperform ratings, citing improving demand and sell-through. Trex is accelerating its Little Rock/Arkansas capacity ramp and plans roughly $100M–$120M in 2026 capital spending to support growth.

Trex Company  ·  Updated Aug 5

Pediatrix reiterated 2026 adjusted EBITDA guidance of $280–$300M, cited stronger pricing and payer mix but softer volumes and higher costs, continued share buybacks and telehybrid/obstetric expansion; Deutsche Bank raised its price target and kept a Hold.

Pediatrix Medical Group  ·  Updated Aug 5